Zheng Quan Zhi Xing·2025-08-05 16:10Core Viewpoint - Guangdong Wannianqing Pharmaceutical Co., Ltd. announced that its major shareholder, Hehe Investment Holdings (Guangzhou) Partnership, plans to reduce its shareholding by up to 4,800,000 shares, representing a maximum of 3.00% of the company's total share capital [1][3]. Summary by Sections Shareholder Reduction Plan - Hehe Investment plans to reduce its holdings within three months starting from fifteen trading days after the announcement date [1][3]. - The reduction will be executed through centralized bidding and block trading methods [1][3]. Recent Shareholding Changes - On August 4, 2025, Hehe Investment reduced its holdings by 895,000 shares, decreasing its ownership from 8.2173125% to 7.6579375%, which is a change of 1% of the total share capital [2]. - The total shares held by Hehe Investment after the reduction are 1,225.27 million shares [2]. Compliance and Regulations - The reduction is in line with the previously disclosed reduction plan, and the actual number of shares reduced does not exceed the planned amount [3][4]. - The company confirms that the reduction does not violate any laws or regulations, and there are no restrictions on the shares being reduced [3][4].